colchicinecanakinumabIL-2 LDIL2 LDatherosclerosisacute coronary syndromesACSMACE
…rdiovascular events (MACE). Anti-inflammatory therapies such as colchicine and canakinumab have reduced MACE in chronic coronary syndromes…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…rdiovascular events (MACE). Anti-inflammatory therapies such as colchicine and canakinumab have reduced MACE in chronic coronary syndromes…
…014). Tonsillectomy was ineffective. IL-1 inhibitors (anakinra, canakinumab) were beneficial in refractory cases. Cluster analysis revealed…
…and responded well to corticosteroids and biologic therapy with canakinumab. This case highlights the diagnostic complexity of AOSD and the…